J.P. Morgan has upgraded Wolters Kluwer to Overweight from Neutral and raised its price target to €87 from €73, saying the move reflects growing conviction that the Dutch information services group is poised to benefit from accelerating AI adoption across its business lines.
The recommendation sent Wolters Kluwer shares up almost 4% in Amsterdam trading following the upgrade.
Analyst Daniel Kerven told clients the upgrade stems from a view that recent investments, corporate acquisitions and the rollout of new AI-enabled products have enhanced the company’s defensive advantage - what he describes as an "AI moat." Rather than depending solely on proprietary content, Kerven emphasized that Wolters Kluwer’s edge is rooted in ownership of mission-critical workflow platforms and systems of record. In this setup, AI is expected to augment long-standing data, regulatory and workflow processes rather than displace them.
On the valuation side, J.P. Morgan lowered its weighted average cost of capital assumptions for Wolters Kluwer’s Legal, Tax and Financial & Corporate Compliance divisions and raised the terminal growth rate used in its model. Those changes, together with a modest currency tailwind, were the primary drivers behind the higher price target. The €87 target equates to a 2027 price-to-earnings multiple of 12.9 times, which the bank notes remains about a 20% discount to peer Pearson.
Kerven observed the stock is trading at roughly 9 times 2027 estimated earnings, representing a 40% discount to RELX and a 60% discount to U.S. peers, according to his analysis. He also flagged potential private equity interest, outlining an illustrative leveraged buyout scenario that could produce a base-case internal rate of return of 17% assuming a 30% takeover premium, with an upside to 23% if select assets such as the Tax division were sold at premium multiples.
The analyst pointed to two recent deals as evidence the company has accelerated its AI roadmap. Wolters Kluwer acquired German legal AI startup Libra in January for roughly €30 million, and in June 2025 it bought Brightflag, an AI-driven legal spend management platform, for about €425 million. Kerven said those transactions lowered the risk that Wolters Kluwer would be slow to respond to AI-driven disruption and opportunity.
Despite the more constructive stance on large parts of the business, J.P. Morgan retains a negative view on the company’s UpToDate clinical information unit. The bank assumes UpToDate’s organic growth will turn negative within five years as it faces competition from AI-native rivals, but it still values the unit at roughly €2.6 billion and attributes that valuation to expected years of positive cash flow.
Kerven described the move as likely the firm’s first substantive upgrade of Wolters Kluwer in 18 months, adding that consensus price targets are only now beginning to adjust to risks that have already been reflected in the share price. The stock has fallen more than 55% over the past 12 months, a decline he used as context for why consensus estimates had lagged the deterioration in investor sentiment.
Note: The article reflects J.P. Morgan’s revised assumptions and Kerven’s analysis as presented to clients, including the specific deal values and valuation metrics cited above.